Literature DB >> 21995155

Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis.

I Kalogiannidis1, S Prapa, T Dagklis, A Karkanaki, S Petousis, Y Prapas, N Prapas.   

Abstract

PURPOSE OF INVESTIGATION: Amniocentesis-related adverse outcomes in singleton pregnancies and possible risk factors for fetal loss after mid-trimester amniocentesis performed in a single institution were investigated.
METHODS: Amniocentesis-related adverse outcomes such as insufficient aspiration of amniotic fluid (AF), repeated puncture, and aspiration of hemorrhagic AF after mid-trimester amniocentesis were reviewed, while special consideration was given according to the placental location. Fetal loss rate up to 24 weeks of gestation and risk factors related to fetal losses were also investigated.
RESULTS: 5,948 cases with the inclusion criteria were analyzed. Advanced maternal age was the most common indication (53%) for amniocentesis. A need for repeated puncture was overall 2.1% (n = 128) and was associated with a fundal placental location. Aspiration of hemorrhagic amniotic fluid was observed in 3.7% (n = 222) and was significantly associated with an anterior or fundal placental position. Fetal loss rate was 0.3% and there was no relationship with advanced maternal age (> or = 35 years), gestational age at amniocentesis > 18 weeks, repeated procedure, aspiration of hemorrhagic AF or placental location.
CONCLUSION: Anterior or fundal placental position is a risk factor for amniocentesis-related adverse outcomes, however without significant contribution to the fetal losses. Placental location, advanced maternal age, amniocentesis gestational age > 18 weeks, and the procedure's adverse outcomes seem to have no impact on fetal loss rate.

Entities:  

Mesh:

Year:  2011        PMID: 21995155

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  3 in total

1.  Does bleeding affect fetal Doppler parameters during genetic amniocentesis?

Authors:  Cantekin Iskender; Ebru Tarım; Tayfun Cok; Hakan Kalaycı; Ayşe Parlakgümüş; Cem Yalçınkaya
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-06-01

2.  Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.

Authors:  Naoki Tajiri; Sandra Acosta; Loren E Glover; Paula C Bickford; Alejandra Jacotte Simancas; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 3.  Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.

Authors:  Naoki Tajiri; Sandra Acosta; Gabriel S Portillo-Gonzales; Daniela Aguirre; Stephanny Reyes; Diego Lozano; Mibel Pabon; Ike Dela Peña; Xunming Ji; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  Front Cell Neurosci       Date:  2014-08-13       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.